NCT06531291 2024-07-31Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine DifferentiationRenJi HospitalPhase 2 Not yet recruiting80 enrolled
NCT06447636 2024-06-07Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction AdenocarcinomaFudan UniversityPhase 2 Not yet recruiting20 enrolled